Your browser doesn't support javascript.
loading
Correction: Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa, T; Osawa, Y; Izumi, T; Nagao, S; Takano, K; Okada, Y; Tachi, N; Teramoto, M; Kawamura, T; Horiuchi, T; Saga, R; Kato, S; Yamamura, T; Watanabe, J; Kobayashi, A; Kobayashi, S; Sato, K; Hashimoto, M; Suzu, S; Kimura, F.
Afiliação
  • Maekawa T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan. dri3011@ndmc.ac.jp.
  • Osawa Y; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Izumi T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Nagao S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Takano K; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Okada Y; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Tachi N; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Teramoto M; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Kawamura T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Horiuchi T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Saga R; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Kato S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Yamamura T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Watanabe J; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Kobayashi A; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Kobayashi S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Sato K; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
  • Hashimoto M; Suzu Project Laboratory, Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
  • Suzu S; Suzu Project Laboratory, Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
  • Kimura F; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Leukemia ; 32(12): 2729-2730, 2018 12.
Article em En | MEDLINE | ID: mdl-30232464
ABSTRACT
Owing to the insufficient specificity of the anti-myeloproliferative leukemia protein (MPL) antibody in the original version of this Article, Figure 6 and parts of Figures 2a, 4e, and 5a do not represent the correct information. The corrected version of Figure 6 is in this correction and those of Figures 2a, 4e, and 5a are shown in the supplemental information.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão